ScholarIQanswers from OpenAlex & ORCID
Maryalice Stetler‐Stevenson
ResearcherPublications, citations & collaboration network
Maryalice Stetler‐Stevenson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Maryalice Stetler‐Stevenson have?
ScholarIQindexed works
Maryalice Stetler‐Stevenson has 380 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Maryalice Stetler‐Stevenson have?
ScholarIQcitation count
Maryalice Stetler‐Stevenson has 29,550 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Maryalice Stetler‐Stevenson?
ScholarIQh-index
Maryalice Stetler‐Stevenson has an h-index of 75 in OpenAlex.
What is the i10-index of Maryalice Stetler‐Stevenson?
ScholarIQi10-index
Maryalice Stetler‐Stevenson has an i10-index of 198 in OpenAlex.
What is the ORCID of Maryalice Stetler‐Stevenson?
ScholarIQorcid
The ORCID for Maryalice Stetler‐Stevenson is on the source record.
What is the OpenAlex record for Maryalice Stetler‐Stevenson?
ScholarIQopenalex
The OpenAlex for Maryalice Stetler‐Stevenson is on the source record.
What are the most-cited papers on Maryalice Stetler‐Stevenson?
ScholarIQmost cited works
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Daniel W Lee, James N. Kochenderfer, Maryalice Stetler‐Stevenson, Yongzhi Cui, Cindy Delbrook, Steven A. Feldman, Terry J. Fry, Rimas J. Orentas, Marianna Sabatino, Nirali N. Shah, Seth M. Steinberg, D. Stroncek, Nick Tschernia, Constance M. Yuan, Hua Zhang, Ling Zhang, Steven A. Rosenberg, Alan S. Wayne, Crystal L. Mackall
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert Somerville, Robert O. Carpenter, Maryalice Stetler‐Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven A. Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, André Goy, Tatyana Feldman, David Spaner, Michael Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg
CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
Terry J. Fry, Nirali N. Shah, Rimas J. Orentas, Maryalice Stetler‐Stevenson, Constance M. Yuan, Sneha Ramakrishna, Pamela L. Wolters, Staci Martin, Cindy Delbrook, Bonnie Yates, Haneen Shalabi, Thomas J. Fountaine, Jack F. Shern, Robbie G. Majzner, David F. Stroncek, Marianna Sabatino, Yang Feng, Dimiter S. Dimitrov, Ling Zhang, Sang M. Nguyen, Haiying Qin, Boro Dropulić, Daniel W Lee, Crystal L. Mackall
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler‐Stevenson, Steven A. Feldman, Irina Marić, Mark Raffeld, Debbie-Ann N. Nathan, Brock Lanier, Richard A. Morgan, Steven A. Rosenberg
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu, Patricia Pérez‐Galán, Delong Liu, Angélique Biancotto, Stefania Pittaluga, Bérengère Vire, Federica Gibellini, Ndegwa Njuguna, Elinor Lee, Lawrence Stennett, Nalini Raghavachari, Poching Liu, J. Philip McCoy, Mark Raffeld, Maryalice Stetler‐Stevenson, Constance M. Yuan, Richard M. Sherry, Diane C. Arthur, Irina Marić, Therese White, Gerald E. Marti, Peter J. Munson, Wyndham H. Wilson, Adrian Wiestner